Last reviewed · How we verify

NCT03757767

The Fasting Study - Unraveling the Mechanistic Effects of Prolonged Fasting in Humans.

Completed NA Last updated 24 April 2019
What this trial tests

NA trial testing Fasting for 26-hours in Fasting in 24 participants. Completed in 22 January 2019.

Timeline
12 November 2018
Primary endpoint
22 January 2019
22 January 2019

Quick facts

Lead sponsorWageningen University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment24
Start date12 November 2018
Primary completion22 January 2019
Estimated completion22 January 2019
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Wageningen University

Who can join

Adults 40 to 70, any sex, with Fasting or Adipose Tissue. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Elevated levels of plasma triglycerides are increasingly recognized as an important causal risk factor for cardiovascular disease and associated pathologies. Lowering plasma triglycerides may therefore be a therapeutic target to lower cardiovascular disease risk. With this study the investigators want to examine the effects of fasting on adipose tissue metabolism in humans.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Fasting induces ANGPTL4 and reduces LPL activity in human adipose tissue.
    Ruppert PMM, Michielsen CCJR, Hazebroek EJ, Pirayesh A, et al · · 2020 · cited 53× · PMID 32504883 · DOI 10.1016/j.molmet.2020.101033

Verify or expand the search:

Other recruiting trials for Fasting

Currently open trials in the same condition.

Other Wageningen University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03757767.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing